Glycosylasparaginase as a marker enzyme in the detection of I-cell disease

Clinical Chemistry

Volumn 44, Issue 12, 1998, Pages 2543-2544

  Ylikangas, Päivi K ^a   Mononen, Ilkka T ^b  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE;

ARTICLE; DIAGNOSTIC VALUE; ENDOCYTOSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYSOSOME; MUCOLIPIDOSIS TYPE 2;

EID: 0031647113     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.12.2543     Document Type: Article

References (16)

1. Noronkoski T, Tollersrud O, Mononen I. Enzymology and structural biology of glycosylasparaginase. In: Mononen I, Aronson NN Jr, eds. Lysosomal storage disease: aspartylglycosaminuria. Heidelberg: Springer Verlag, 1997:77-100.
2. Fisher KJ, Aronson NN. Characterization of the mutation responsible for aspartylglucosaminuria in three Finnish patients. J Biol Chem 1991;266: 12105-13.
3. Ikonen E, Julkunen I, Tollersrud O-K, Kalkkinen N, Peltonen L. Lysosomal aspartylglucosaminidase is processed to the active subunit complex in the endoplasmic reticulum. EMBO J 1993;12:295-302.
4. Kaartinen V. Williams JC, Tomich J, Yates JR III, Hood LE, Mononen I. Glycosylasparaginase from human leukocytes. Inactivation and covalent modification with diazo-oxonorvaline. J Biol Chem 1991;266:5860-9.
5. Mononen I, Heisterkamp N, Dunder U, Romppanen E-L, Noronkoski T, Kuronen I, Groffen J. Recombinant glycosylasparaginase and in vitro correction of aspartylglycosaminuria. FASEB J 1995;9:428-33.
6. Wiesmann UN, Lightbody J, Vasella F, Herschkowitz N. Multiple enzyme deficiency due to enzyme leakage. N Engl J Med 1971;284:109-10.
7. Mueller TO, Little LE, Miller AL, Lozzio CB, Shows TB. I-Cell disease and pseudo-Hurler polydystrophy: heterozygote detection and characteristics of the altered N-acetyl-glucosamine-phosphotransferase in genetic variants. Clin Chim Acta 1985;150:175-83.
8. Kornfeld S, Sly WS. I-Cell disease and pseudo-Hurler polydystrophy. Disorders of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill. 1995:2495-508.
9. Leroy JG, Ho MW, MacBrinn MC, Zielke K. Jakob J, O'Brien JS. I-Cell disease: biochemical studies. Pediatr Res 1972;6:752-7.
10. Erickson AH, Ginns EI, Barranger JA. Biosynthesis of the lysosomal enzyme glucocerebrosidase. J Biol Chem 1985;260:14319-24.
11. Waheed A, Gottschalk S, Hille A, Krentler C, Pohlmann R, Braulke T, et al. Human lysosomal acid phosphatase is transported as a transmembrane protein to lysosomes in transfected baby hamster kidney cells. EMBO J 1988;7:2351-8.
12. Mononen IT, Kaartinen VM, Williams JC. A fluorometric assay for glycosylasparaginase activity and detection of aspartylglycosaminuria. Anal Biochem 1993;208:372-4.
13. Mononen I, Mononen T, Ylikangas P, Kaartinen V, Savolainen K. Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase in serum, plasma or lymphocytes. Clin Chem 1994;40:2941-5.
14. Christomanou H, Sandhoff K. A sensitive fluorescence assay for the simultaneous and separate determination of arylsulphatases A and B. Clin Chim Acta 1977;79:527-31.
15. Guan C, Cui T, Rao V, Liao W, Benner J, Lin CL, Comb D. Activation of glycosylasparaginase. Formation of active N-terminal threonine by intramolecular autoproteolysis. J Biol Chem 1996;271:1732-7.
16. Mononen I, Ylikangas P, Mononen T, Savolainen K. Neonatal detection of aspartylglycosaminuria. Lancet 1994;343:1297-8.